Dane Andreeff - 22 Nov 2022 Form 4/A - Amendment Insider Report for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Dane Andreeff
Issuer symbol: HSDT
Transactions as of: 22 Nov 2022
Net transactions value: +$29,613
Form type: 4/A - Amendment
Filing time: 25 Nov 2022, 15:26:46 UTC
Date Of Original Report: 23 Nov 2022
Previous filing: 18 Nov 2022
Next filing: 19 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HSDT	Common Stock	Purchase	$2,919	+10,300	+4.9%	$0.2834	218,872	22 Nov 2022	See footnote	F1, F2
transaction	HSDT	Common Stock	Purchase	$13,149	+42,185	+19%	$0.3117	261,057	23 Nov 2022	See footnote	F1, F2
transaction	HSDT	Common Stock	Purchase	$3,150	+10,105	+23%	$0.3117	54,025	23 Nov 2022	See footnote	F1, F3
transaction	HSDT	Common Stock	Purchase	$9,613	+30,841	+11%	$0.3117	306,923	23 Nov 2022	See footnote	F1, F4
transaction	HSDT	Common Stock	Purchase	$782	+2,509	+23%	$0.3117	13,439	23 Nov 2022	See footnote	F1, F5
holding	HSDT	Common Stock						1,508	22 Nov 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This Form 4/A is being filed to amend an inadvertent error in the number of shares purchased by the Reporting Person in the Form 4 previously filed on November 23, 2022.
F2	The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F3	The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities owned by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F4	The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F5	The shares are held by Maple Leaf Offshore Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.